| Author/Editor | Štuhec, Matej | |
| Title | Identifikacija in ozadje neželenih učinkov zdravil pri psihiatričnih bolnikih | |
| Translated title | An identification of the adverse drug reactions and its background in psychiatric patients | |
| Type | članek | |
| Vol. and No. | Letnik 65, št. 1 | |
| Publication year | 2014 | |
| Volume | str. 11-17 | |
| ISSN | 0014-8229 - Farmacevtski vestnik | |
| Language | slv | |
| Abstract | Neželeni učinki zdravil so veliko breme javnega zdravstvenega sistema, saj predstavljajo precejšen delež sprejemov v bolnišnice. Neželeni učinki so pogosto povezani s psihofarmaki. Psihofarmaki z najbolj ugodnim varnostnim profilom so antidepresivi, sledijo antipsihotiki in antiepileptiki. Veliko zdravil povzroča tudi psihiatrične neželene učinke. Ob pojavu resnega neželenega učinka zdravil pri bolniku je potrebno nenadoma ukiniti zdravilo, ki je najverjetneje povzročilo neželeni učinek. Diagnoza neželenih učinkov je pogosto negotova, zato morata zdravnik in klinični farmacevt pri zdravljenju psihiatrične motnje pretehtati tveganje med resnostjo neželenega učinka in možnostjo ponovitve psihiatrične motnje ob ukinitvi zdravila. Za doseganje optimalnih kliničnih izidov, v smislu učinkovitosti in varnosti, pri psihiatričnih bolnikih je potrebna vključitev kliničnega farmacevta v proces zdravljenja z zdravili in njegovo sodelovanje z zdravnikom.Adverse drug reactions have been regarded as a major public health problem since they represent a sizable percentage of hospital admissions. Adverse drug reactions are also frequently associated with psychopharmaceuticals. The safest psychopharmaceuticals are antidepressants followed by antipsychotics and antiepileptics. Also, many drugs can cause psychiatric adverse effects. When a severe drug reaction develops the suspected causal agent should be with drawn immediately. Since the diagnosis of an adverse drug reaction is often tentative, when treating a patient with a psychiatric disorder the physician and clinical pharmacist must weigh the risk of developing these potential problems against the possibility of relapse of the psychiatric disorder should the medication be discontinued. The inclusion of a clinical pharmacist in the psychiatric patient&x02BC;s pharmacotherapy and his cooperation with physician are necessary for optimal clinical outcomes in term of efficacy and safety. | |
| Descriptors | Klinična farmacija | |
| Keywords | neželeni učinki zdravil psihofarmaki psihiatrični bolniki |